Log In
BCIQ
Print this Print this
 

MUT37307

  Manage Alerts
Collapse Summary General Information
Company Mutabilis S.A.
DescriptionInhibitor of fabI enoyl-(acyl carrier protein) reductase
Molecular Target fabI enoyl-(acyl carrier protein) reductase
Mechanism of ActionfabI enoyl-(acyl carrier protein) reductase inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationStaphylococcus
Indication DetailsTreat methicillin-resistant Staphylococcus aureus (MRSA) infection
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today